Edwards Lifesciences VP Exercises 13,457 Stock Units
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Donald E. Bobo Jr., CVP, Strategy/Corporate Development, reported the vesting and exercise of performance-based restricted stock units into 13,457 shares of common stock on May 11, 2026, after the board’s Compensation and Governance Committee certified 167.70% of the target award for vesting as of that date.
To satisfy related tax liability, 7,469 shares of common stock were withheld at $79.96 per share. Following these equity compensation transactions, he directly holds 32,766.2532 shares of Edwards Lifesciences common stock, alongside indirect holdings of 38,969.5756 shares in a 401(k) plan and 121,756 shares held by a trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Rights | 13,457 | $0.00 | $0.00 |
| Exercise | Common Stock | 13,457 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 7,469 | $79.96 | $597K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
- F2. These Performance Rights expire on May 10, 2030.
Key Figures
Key Terms
Performance Rights financial
restricted stock units financial
performance-based vesting requirements financial
tax-withholding disposition financial
401(k) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Donald E. Bobo Jr. report in Edwards Lifesciences (EW) Form 4?
What performance conditions applied to the Edwards Lifesciences (EW) award?
Were any derivative securities exercised or canceled in the EW Form 4?
When do the Edwards Lifesciences (EW) Performance Rights mentioned in the filing expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.